KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Other Accumulated Expenses (2009 - 2014)

Edwards Lifesciences' quarterly Other Accumulated Expenses came in at $4.4 million in Q4 2014, down 2.22% year-on-year from $4.5 million in Q4 2013, and down 94.69% quarter-over-quarter from $82.8 million in Q3 2014.

Edwards Lifesciences has reported Other Accumulated Expenses for 6 years, with the latest figure at $4.4 million in Q4 2014.

  • For the quarter ending Q4 2014, Other Accumulated Expenses fell 2.22% year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2014 stood at $4.4 million (down 2.22% YoY), and the FY2014 full-year result was $4.4 million, down 2.22% from the prior year.
  • Other Accumulated Expenses for Q4 2014 stood at $4.4 million, down from $82.8 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $82.8 million in Q3 2014, with the low at $4.4 million in Q4 2014.
  • Average Other Accumulated Expenses over 5 years is $38.5 million, with a median of $33.9 million recorded in 2010.
  • Year-over-year, Other Accumulated Expenses soared 986.36% in 2012 and plunged 93.72% in 2013.
  • Tracing EW's Other Accumulated Expenses over 5 years: stood at $61.2 million in 2010, then sank by 89.22% to $6.6 million in 2011, then soared by 986.36% to $71.7 million in 2012, then sank by 93.72% to $4.5 million in 2013, then retreated by 2.22% to $4.4 million in 2014.
  • The last three Other Accumulated Expenses figures came in at $4.4 million (Q4 2014), $82.8 million (Q3 2014), and $4.5 million (Q4 2013), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2014 4.40 Mn
Sep 30, 2014 82.80 Mn
Dec 31, 2013 4.50 Mn
Dec 31, 2012 71.70 Mn
Dec 31, 2011 6.60 Mn
Dec 31, 2010 61.20 Mn
Dec 31, 2009 25.70 Mn